Guidance For Improving Vaccine Uptake Published By WHO TAG 04/12/2020 Editorial team As the first vaccination campaign for COVID-19 could begin as early as next week, following the UK’s approval Pfizer and BioNTech’s mRNA vaccine, the World Health Organisation (WHO) technical advisory group (TAG) has published a series of guidelines and behavioural insights to improve vaccine acceptance and uptake across all populations. The report, published on Friday, […] Continue reading -> Economic Benefits Of Equitable Vaccine & Medicines Distribution Would Be 12 Times Costs to Donor Countries, Says Study 04/12/2020 Raisa Santos The economic benefits to the economies of ten high income countries being asked to support the equitable, worldwide distribution of COVID-19 vaccines, treatments and tests would be 12 times the costs, a new report has found. The study, undertaken by the global political risk research firm Eurasia Group, on behalf of the Bill and Melinda […] Continue reading -> UN Commission On Narcotic Drugs Approves WHO Recommendation Removing Cannabis From List of Most Deadly Narcotics 03/12/2020 Elaine Ruth Fletcher The UN Commission on Narcotic Drugs voted on Wednesday to remove cannabis and cannabis-derived substances from its “Schedule IV” list of the world’s most dangerous narcotics. The move comes nearly two years after the WHO recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention […] Continue reading -> Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week 02/12/2020 Elaine Ruth Fletcher Pfizer’s COVID-19 vaccine, a cutting edge mRNA technology produced jointly with the German firm BioNTech, was authorized for use on Wednesday by the United Kingdom – making it the vaccine the first to be rolled out for commercial public use as early as next week. The vaccine was authorised Wednesday morning for emergency use by […] Continue reading -> Key HIV Treatment To Be Rolled Out Among More Children & Adults In Low- And Middle-Income Countries 01/12/2020 J Hacker Two groundbreaking agreements with pharma companies that should greatly expand access to WHO-recommended HIV drugs for children and adults in low- and middle-income countries (LMICs) have been announced by the Geneva-based Unitaid and Medicines Patent Pool (MPP). The announcements, coinciding with World AIDS Day, celebrated on Tuesday 1 December, both involve cheaper versions or new […] Continue reading -> COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> The COVID-19 Crisis Is A Signal – Need To ‘Reset’ Global Health Financing 27/11/2020 Ilona Kickbusch We are kicking off our expanded new series of opinion pieces, with Ilona Kickbusch’s reflections on last week’s G-20 and the mission of COVID vaccine distribution – what she describes as the most “defining global challenge” of 2021. We invite contributions from health policy leaders, influencers and practitioners who wish to speak out on issues […] Continue reading -> Africa’s COVID Vaccine Roll-Out Depends On Restoring Other Vaccination Programs 27/11/2020 Paul Adepoju Africa’s COVID-19 rollout is anticipated for Spring 2021, despite the continent’s low vaccine preparedness, multiple health leaders in Africa have said, as policy advisory groups flag the importance that other successful immunization campaigns will have on COVID recovery. At a press briefing on Thursday, Dr. John Nkengasong, Director of Africa CDC, said: “Africa may have […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Economic Benefits Of Equitable Vaccine & Medicines Distribution Would Be 12 Times Costs to Donor Countries, Says Study 04/12/2020 Raisa Santos The economic benefits to the economies of ten high income countries being asked to support the equitable, worldwide distribution of COVID-19 vaccines, treatments and tests would be 12 times the costs, a new report has found. The study, undertaken by the global political risk research firm Eurasia Group, on behalf of the Bill and Melinda […] Continue reading -> UN Commission On Narcotic Drugs Approves WHO Recommendation Removing Cannabis From List of Most Deadly Narcotics 03/12/2020 Elaine Ruth Fletcher The UN Commission on Narcotic Drugs voted on Wednesday to remove cannabis and cannabis-derived substances from its “Schedule IV” list of the world’s most dangerous narcotics. The move comes nearly two years after the WHO recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention […] Continue reading -> Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week 02/12/2020 Elaine Ruth Fletcher Pfizer’s COVID-19 vaccine, a cutting edge mRNA technology produced jointly with the German firm BioNTech, was authorized for use on Wednesday by the United Kingdom – making it the vaccine the first to be rolled out for commercial public use as early as next week. The vaccine was authorised Wednesday morning for emergency use by […] Continue reading -> Key HIV Treatment To Be Rolled Out Among More Children & Adults In Low- And Middle-Income Countries 01/12/2020 J Hacker Two groundbreaking agreements with pharma companies that should greatly expand access to WHO-recommended HIV drugs for children and adults in low- and middle-income countries (LMICs) have been announced by the Geneva-based Unitaid and Medicines Patent Pool (MPP). The announcements, coinciding with World AIDS Day, celebrated on Tuesday 1 December, both involve cheaper versions or new […] Continue reading -> COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> The COVID-19 Crisis Is A Signal – Need To ‘Reset’ Global Health Financing 27/11/2020 Ilona Kickbusch We are kicking off our expanded new series of opinion pieces, with Ilona Kickbusch’s reflections on last week’s G-20 and the mission of COVID vaccine distribution – what she describes as the most “defining global challenge” of 2021. We invite contributions from health policy leaders, influencers and practitioners who wish to speak out on issues […] Continue reading -> Africa’s COVID Vaccine Roll-Out Depends On Restoring Other Vaccination Programs 27/11/2020 Paul Adepoju Africa’s COVID-19 rollout is anticipated for Spring 2021, despite the continent’s low vaccine preparedness, multiple health leaders in Africa have said, as policy advisory groups flag the importance that other successful immunization campaigns will have on COVID recovery. At a press briefing on Thursday, Dr. John Nkengasong, Director of Africa CDC, said: “Africa may have […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UN Commission On Narcotic Drugs Approves WHO Recommendation Removing Cannabis From List of Most Deadly Narcotics 03/12/2020 Elaine Ruth Fletcher The UN Commission on Narcotic Drugs voted on Wednesday to remove cannabis and cannabis-derived substances from its “Schedule IV” list of the world’s most dangerous narcotics. The move comes nearly two years after the WHO recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention […] Continue reading -> Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week 02/12/2020 Elaine Ruth Fletcher Pfizer’s COVID-19 vaccine, a cutting edge mRNA technology produced jointly with the German firm BioNTech, was authorized for use on Wednesday by the United Kingdom – making it the vaccine the first to be rolled out for commercial public use as early as next week. The vaccine was authorised Wednesday morning for emergency use by […] Continue reading -> Key HIV Treatment To Be Rolled Out Among More Children & Adults In Low- And Middle-Income Countries 01/12/2020 J Hacker Two groundbreaking agreements with pharma companies that should greatly expand access to WHO-recommended HIV drugs for children and adults in low- and middle-income countries (LMICs) have been announced by the Geneva-based Unitaid and Medicines Patent Pool (MPP). The announcements, coinciding with World AIDS Day, celebrated on Tuesday 1 December, both involve cheaper versions or new […] Continue reading -> COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> The COVID-19 Crisis Is A Signal – Need To ‘Reset’ Global Health Financing 27/11/2020 Ilona Kickbusch We are kicking off our expanded new series of opinion pieces, with Ilona Kickbusch’s reflections on last week’s G-20 and the mission of COVID vaccine distribution – what she describes as the most “defining global challenge” of 2021. We invite contributions from health policy leaders, influencers and practitioners who wish to speak out on issues […] Continue reading -> Africa’s COVID Vaccine Roll-Out Depends On Restoring Other Vaccination Programs 27/11/2020 Paul Adepoju Africa’s COVID-19 rollout is anticipated for Spring 2021, despite the continent’s low vaccine preparedness, multiple health leaders in Africa have said, as policy advisory groups flag the importance that other successful immunization campaigns will have on COVID recovery. At a press briefing on Thursday, Dr. John Nkengasong, Director of Africa CDC, said: “Africa may have […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week 02/12/2020 Elaine Ruth Fletcher Pfizer’s COVID-19 vaccine, a cutting edge mRNA technology produced jointly with the German firm BioNTech, was authorized for use on Wednesday by the United Kingdom – making it the vaccine the first to be rolled out for commercial public use as early as next week. The vaccine was authorised Wednesday morning for emergency use by […] Continue reading -> Key HIV Treatment To Be Rolled Out Among More Children & Adults In Low- And Middle-Income Countries 01/12/2020 J Hacker Two groundbreaking agreements with pharma companies that should greatly expand access to WHO-recommended HIV drugs for children and adults in low- and middle-income countries (LMICs) have been announced by the Geneva-based Unitaid and Medicines Patent Pool (MPP). The announcements, coinciding with World AIDS Day, celebrated on Tuesday 1 December, both involve cheaper versions or new […] Continue reading -> COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> The COVID-19 Crisis Is A Signal – Need To ‘Reset’ Global Health Financing 27/11/2020 Ilona Kickbusch We are kicking off our expanded new series of opinion pieces, with Ilona Kickbusch’s reflections on last week’s G-20 and the mission of COVID vaccine distribution – what she describes as the most “defining global challenge” of 2021. We invite contributions from health policy leaders, influencers and practitioners who wish to speak out on issues […] Continue reading -> Africa’s COVID Vaccine Roll-Out Depends On Restoring Other Vaccination Programs 27/11/2020 Paul Adepoju Africa’s COVID-19 rollout is anticipated for Spring 2021, despite the continent’s low vaccine preparedness, multiple health leaders in Africa have said, as policy advisory groups flag the importance that other successful immunization campaigns will have on COVID recovery. At a press briefing on Thursday, Dr. John Nkengasong, Director of Africa CDC, said: “Africa may have […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Key HIV Treatment To Be Rolled Out Among More Children & Adults In Low- And Middle-Income Countries 01/12/2020 J Hacker Two groundbreaking agreements with pharma companies that should greatly expand access to WHO-recommended HIV drugs for children and adults in low- and middle-income countries (LMICs) have been announced by the Geneva-based Unitaid and Medicines Patent Pool (MPP). The announcements, coinciding with World AIDS Day, celebrated on Tuesday 1 December, both involve cheaper versions or new […] Continue reading -> COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> The COVID-19 Crisis Is A Signal – Need To ‘Reset’ Global Health Financing 27/11/2020 Ilona Kickbusch We are kicking off our expanded new series of opinion pieces, with Ilona Kickbusch’s reflections on last week’s G-20 and the mission of COVID vaccine distribution – what she describes as the most “defining global challenge” of 2021. We invite contributions from health policy leaders, influencers and practitioners who wish to speak out on issues […] Continue reading -> Africa’s COVID Vaccine Roll-Out Depends On Restoring Other Vaccination Programs 27/11/2020 Paul Adepoju Africa’s COVID-19 rollout is anticipated for Spring 2021, despite the continent’s low vaccine preparedness, multiple health leaders in Africa have said, as policy advisory groups flag the importance that other successful immunization campaigns will have on COVID recovery. At a press briefing on Thursday, Dr. John Nkengasong, Director of Africa CDC, said: “Africa may have […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> The COVID-19 Crisis Is A Signal – Need To ‘Reset’ Global Health Financing 27/11/2020 Ilona Kickbusch We are kicking off our expanded new series of opinion pieces, with Ilona Kickbusch’s reflections on last week’s G-20 and the mission of COVID vaccine distribution – what she describes as the most “defining global challenge” of 2021. We invite contributions from health policy leaders, influencers and practitioners who wish to speak out on issues […] Continue reading -> Africa’s COVID Vaccine Roll-Out Depends On Restoring Other Vaccination Programs 27/11/2020 Paul Adepoju Africa’s COVID-19 rollout is anticipated for Spring 2021, despite the continent’s low vaccine preparedness, multiple health leaders in Africa have said, as policy advisory groups flag the importance that other successful immunization campaigns will have on COVID recovery. At a press briefing on Thursday, Dr. John Nkengasong, Director of Africa CDC, said: “Africa may have […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The COVID-19 Crisis Is A Signal – Need To ‘Reset’ Global Health Financing 27/11/2020 Ilona Kickbusch We are kicking off our expanded new series of opinion pieces, with Ilona Kickbusch’s reflections on last week’s G-20 and the mission of COVID vaccine distribution – what she describes as the most “defining global challenge” of 2021. We invite contributions from health policy leaders, influencers and practitioners who wish to speak out on issues […] Continue reading -> Africa’s COVID Vaccine Roll-Out Depends On Restoring Other Vaccination Programs 27/11/2020 Paul Adepoju Africa’s COVID-19 rollout is anticipated for Spring 2021, despite the continent’s low vaccine preparedness, multiple health leaders in Africa have said, as policy advisory groups flag the importance that other successful immunization campaigns will have on COVID recovery. At a press briefing on Thursday, Dr. John Nkengasong, Director of Africa CDC, said: “Africa may have […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa’s COVID Vaccine Roll-Out Depends On Restoring Other Vaccination Programs 27/11/2020 Paul Adepoju Africa’s COVID-19 rollout is anticipated for Spring 2021, despite the continent’s low vaccine preparedness, multiple health leaders in Africa have said, as policy advisory groups flag the importance that other successful immunization campaigns will have on COVID recovery. At a press briefing on Thursday, Dr. John Nkengasong, Director of Africa CDC, said: “Africa may have […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Posts navigation Older postsNewer posts